Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients

NCT: NCT02922036 · ACTIVE_NOT_RECRUITING

NCT IDNCT02922036
StatusACTIVE_NOT_RECRUITING
Start Date2018-01-17
SponsorEBR Systems, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

This study is a prospective, multi-center, pivotal trial to study the safety and efficacy of the WiSE-CRT System for Cardiac Re-synchronization Therapy.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑